Sharp’s Heerenveen facility provides both large-scale and specialised small-batch packaging capacity in shared or dedicated production suites. We offer expertise and capabilities in multiple specialist formats, and enables access to the EU market through in-house QP services. 

Our facility also offers a complete range of specialized cold chain packaging and labelling services for gene therapy products. A specialist infrastructure is in place including temperature and humidity controls and monitoring, and full -80°C freezer banks in shared or dedicated packaging suites. 

Sharp Heerenveen holds also a European clinical services depot offering distribution and QP release services for investigational medicinal products (IMPs) in conjunction with our site in Rhymney, UK.

Facility Highlights

  • 8,500 m2 (92,100 ft2) facility including GMP production space, warehouse and offices
  • Ambient and refrigerated (2-8°C) packaging, storage, and distribution
  • Frozen (-80°C) storage and distribution
  • Shared and dedicated production areas
  • Controlled drug management
  • Manufacturing License for Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP)
  • Electronic Batch Record (EBR) generated via our Manufacturing Execution Systems (MES)
  • Gene therapy small-batch cold chain packaging suite
    • Optimal environment and specialist infrastructure
    • Dedicated HVAC air handling
    • Temperature and humidity controls and monitoring
    • Full -80°C freezer banks in dedicated production suites

Contract Services

Secondary packaging

Quality Accreditation

  • Regulated by Dutch Health and Youth Care Inspectorate (IGJ)
  • Ministry of Health of the Republic of Belarus – inspected
  • Ministry of Industry and Trade of the Russian Federation – inspected
  • Manufacturing License 108630F WDA 16273G
  • GMP certified


Neptunus 12
8448 CN Heerenveen
The Netherlands
Tel: +31 513 433 947

Accommodation Nearby